These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 28483209

  • 1. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
    Golive A, May HT, Bair TL, Jacobs V, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch TJ.
    Am J Cardiol; 2017 Jul 01; 120(1):75-82. PubMed ID: 28483209
    [Abstract] [Full Text] [Related]

  • 2. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW, Lau WC, Siu CW, Lip GY, Leung WK, Anand S, Man KK, Wong IC.
    Heart Rhythm; 2016 Aug 01; 13(8):1581-8. PubMed ID: 27033342
    [Abstract] [Full Text] [Related]

  • 3. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S, Olesen JB, Clémenty N, Lagrenade I, Babuty D, Lip GY, Fauchier L.
    J Cardiovasc Electrophysiol; 2012 Jul 01; 23(7):708-13. PubMed ID: 22268375
    [Abstract] [Full Text] [Related]

  • 4. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E, Wolff A, Lip GY, Lane DA.
    Br J Gen Pract; 2015 Jan 01; 65(630):e16-23. PubMed ID: 25548312
    [Abstract] [Full Text] [Related]

  • 5. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F, Renlund H, Lip GY, Wester P, Svensson PJ, Själander A.
    JAMA Cardiol; 2016 May 01; 1(2):172-80. PubMed ID: 27437888
    [Abstract] [Full Text] [Related]

  • 6. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 7. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.
    Heart Rhythm; 2015 Apr 10; 12(4):681-6. PubMed ID: 25546809
    [Abstract] [Full Text] [Related]

  • 8. Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS2 and CHA2DS2-VASc score levels and warfarin prescription for adult patients with atrial fibrillation.
    Chapman SA, St Hill CA, Little MM, Swanoski MT, Scheiner SR, Ware KB, Lutfiyya MN.
    BMC Health Serv Res; 2017 Feb 11; 17(1):127. PubMed ID: 28187730
    [Abstract] [Full Text] [Related]

  • 9. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y, Wang H, Tian Y, Wang Y, Lip GYH.
    Chest; 2015 Jul 11; 148(1):62-72. PubMed ID: 25501045
    [Abstract] [Full Text] [Related]

  • 10. Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patients.
    Jacobs V, May HT, Bair TL, Crandall BG, Cutler DO MJ, Day JD, Mallender C, Osborn JS, Weiss JP, Bunch TJ.
    J Cardiovasc Electrophysiol; 2017 Nov 11; 28(11):1241-1246. PubMed ID: 28845890
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Liao JN, Chen TJ, Lip GY, Chen SA.
    Heart Rhythm; 2014 Oct 11; 11(10):1752-9. PubMed ID: 24952148
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L, Fauchier L, Nonin E, de Labriolle A, Haguenoer K, Cosnay P, Babuty D, Charbonnier B.
    Thromb Haemost; 2010 Apr 11; 103(4):833-40. PubMed ID: 20135077
    [Abstract] [Full Text] [Related]

  • 15. CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.
    Kim TH, Yang PS, Kim D, Yu HT, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, Lip GYH.
    Stroke; 2017 Nov 11; 48(11):2984-2990. PubMed ID: 28939672
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L, DeLosSantos M, Smotherman C.
    J Cardiovasc Pharmacol Ther; 2018 Nov 11; 23(6):502-508. PubMed ID: 29806486
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J, Bothner C, Dahme T, Gonska B, Scharnbeck D, Markovic S, Rottbauer W, Wöhrle J.
    Clin Res Cardiol; 2016 Mar 11; 105(3):225-9. PubMed ID: 26318322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry.
    Katz DF, Maddox TM, Turakhia M, Gehi A, O'Brien EC, Lubitz SA, Turchin A, Doros G, Lei L, Varosy P, Marzec L, Hsu JC.
    Circ Cardiovasc Qual Outcomes; 2017 May 11; 10(5):. PubMed ID: 28506981
    [Abstract] [Full Text] [Related]

  • 20. Bleeding risk in patients with atrial fibrillation: the AMADEUS study.
    Lane DA, Kamphuisen PW, Minini P, Büller HR, Lip GYH.
    Chest; 2011 Jul 11; 140(1):146-155. PubMed ID: 21415134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.